Who owns Strata Critical Medical, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of SRTA from SEC Form 13F filings across 103 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 103 institutions disclosed 35.5M shares of Strata Critical Medical, Inc. worth $186.8M — about 41.2% of shares outstanding; the largest disclosed holder is Third Point LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
103
13F holders
$186.8M
value, 2026 filers
41.2%
of shares outstanding (35.5M sh)
21
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of SRTA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Third Point LLC | 5.0M | $26.4M | 0.6% | 5.8% | 0.0% |
| 2 | BlackRock, Inc. | 4.8M | $25.5M | 0.0% | 5.6% | +5.9% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 2.9M | $15.2M | 0.0% | 3.3% | -49.8% |
| 4 | Uniplan Investment Counsel, Inc. | 2.9M | $15.1M | 1.4% | 3.3% | +119.9% |
| 5 | ARK Investment Management LLC | 2.7M | $14.4M | 0.1% | 3.2% | -63.4% |
| 6 | First Eagle Investment Management, LLC | 2.3M | $12.2M | 0.0% | 2.7% | -48.9% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.8M | $9.3M | 0.0% | 2% | +3.3% |
| 8 | Bank of New York Mellon Corp | 1.1M | $6.0M | 0.0% | 1.3% | +5.7% |
| 9 | Sumitomo Mitsui Trust Group, Inc. | 1.1M | $5.5M | 0.0% | 1.2% | -36.4% |
| 10 | Amova Asset Management Americas, Inc. | 989,100 | $5.2M | 0.1% | 1.1% | -40.2% |
| 11 | NORTHERN TRUST CORP | 676,575 | $3.6M | 0.0% | 0.8% | +5.1% |
| 12 | CITIGROUP INC | 526,859 | $2.8M | 0.0% | 0.6% | +445.2% |
| 13 | VANGUARD PORTFOLIO MANAGEMENT LLC | 526,143 | $2.8M | 0.0% | 0.6% | +8.8% |
| 14 | Qube Research & Technologies LtdNEW | 524,627 | $2.8M | 0.0% | 0.6% | new |
| 15 | PRELUDE CAPITAL MANAGEMENT, LLC | 503,872 | $2.7M | 0.2% | 0.6% | -6.6% |
| 16 | Cerity Partners LLC | 502,238 | $2.6M | 0.0% | 0.6% | +100.0% |
| 17 | GOLDMAN SACHS GROUP INC | 471,528 | $2.5M | 0.0% | 0.5% | +13.8% |
| 18 | VANGUARD FIDUCIARY TRUST CO | 454,346 | $2.4M | 0.0% | 0.5% | +5.1% |
| 19 | Russell Investments Group, Ltd. | 429,673 | $2.3M | 0.0% | 0.5% | +17.3% |
| 20 | MORGAN STANLEY | 425,398 | $2.2M | 0.0% | 0.5% | -14.6% |
| 21 | JANE STREET GROUP, LLC | 354,373 | $1.9M | 0.0% | 0.4% | +50.0% |
| 22 | BOOTHBAY FUND MANAGEMENT, LLC | 343,014 | $1.8M | 0.0% | 0.4% | -24.4% |
| 23 | Nuveen, LLC | 332,890 | $1.8M | 0.0% | 0.4% | +126.5% |
| 24 | JPMORGAN CHASE & CO | 316,354 | $1.6M | 0.0% | 0.4% | -1.2% |
| 25 | UBS Group AG | 285,137 | $1.5M | 0.0% | 0.3% | -2.9% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.